We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Light-Sensitive Nanoparticles Designed for Smart Drug Release

By LabMedica International staff writers
Posted on 14 Feb 2018
Print article
Image: Vials containing samples of \"hairy\" nanoparticles: the right and left vials contain photo-responsive polymer-capped gold nanoparticles prior to and after self-assembly, respectively. The center vial shows dye released from self-assembled gold nanoparticles. The nanoparticles were made with light-sensitive materials that assembled and disassembled themselves when exposed to light of different wavelengths (Photo courtesy of Rob Felt, Georgia Institute of Technology).
Image: Vials containing samples of \"hairy\" nanoparticles: the right and left vials contain photo-responsive polymer-capped gold nanoparticles prior to and after self-assembly, respectively. The center vial shows dye released from self-assembled gold nanoparticles. The nanoparticles were made with light-sensitive materials that assembled and disassembled themselves when exposed to light of different wavelengths (Photo courtesy of Rob Felt, Georgia Institute of Technology).
A novel type of "smart" nanoparticles responds to light of specific wavelengths that causes the particles to assemble or disassemble, which enables the dynamic organization of the nanoparticles for in vitro drug release.

The ability to dynamically organize functional nanoparticles (NPs) via the use of environmental triggers (temperature, pH, light, or solvent polarity) opens up important perspectives for rapid and convenient construction of a rich variety of complex assemblies and materials with new structures and functionalities.

In a study published in the January 31, 2018, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences, investigators at the Georgia Institute of Technology (Atlanta, USA) described an unconventional strategy for crafting stable "hairy" NPs with light-enabled reversible and reliable self-assembly and tunable optical properties.

The "hairy" nanoparticles were fabricated around a tiny core of beta-cyclodextrin from which polymer chains of poly(acrylicacid)-block-poly(7-methylacryloyloxy-4-methylcoumarin) (PAA-b-PMAMC) were grown. This compound attracted water-soluble metal precursors, which utilized the space within the polymer hairs as nano-reactors to form gold nanoparticles. The investigators then added hairs made from the light sensitive hydrophobic monomer MAMC.

Light at a wavelength of 365 nanometers induced the nanoparticles to self-assemble through a photo-dimerization process, while the process was reversed when the particles were exposed to light at 254 nanometers.

“Under light, the assemblies of photo-sensitive nanoparticles separate over a period of hours at a rate that can be controlled by the intensity and wavelength of the light,” said senior author Dr. Zhiqun Lin, professor of materials science and engineering at the Georgia Institute of Technology. “Because the disassembly can be turned on and off at will, we could provide a timed release of the drug by controlling the short-wavelength light exposure. Once the polymer chains from adjacent gold nanoparticles begin to photo-crosslink, they bring nanoparticles together via a self-assembly process to generate large assemblies of nanoparticles. This process is completely reversible and can be repeated in many cycles.”

“We envision that these photo-responsive polymer-capped gold nanoparticles could one day serve as nano-carriers for drug delivery into the body using our robust and reversible process for assembly and disassembly,” said Dr. Lin. “Used in cancer therapy, this process could increase the impact of a treatment by heating the cancer cells while introducing the drug compound into the tumor.”

Related Links:
Georgia Institute of Technology

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.